Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Henney · SciRah

Researcher profile · Semantic Scholar

H. Henney

Share profile

H. Henney — researcher profile on SciRah

h-index: 13
Works: 30
Citations: 749

Most-cited papers

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
A. Maas, G. Murray, H. Henney, N. Kassem +5 more
2006Lancet Neurology265 citations
Semantic Scholar
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials
A. Goodman, F. Bethoux, T. Brown, R. Schapiro +4 more
2015Multiple Sclerosis52 citations Open access
Semantic Scholar
A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury
L. Kamen, H. Henney, J. D. Runyan
200844 citations
Semantic Scholar
A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
L. Kamen, H. Henney, J. D. Runyan
2008Current Medical Research and Opinion43 citations
Semantic Scholar
Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
A. Blight, H. Henney
2009Clinical Therapeutics41 citations
Semantic Scholar
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trial.
T. Vollmer, H. Henney
2009Clinical Therapeutics40 citations
Semantic Scholar
Single‐Dose Pharmacokinetics of Sustained‐Release Fampridine (Fampridine‐SR) in Healthy Volunteers and Adults With Renal Impairment
William B. Smith, S. Swan, T. Marbury, H. Henney
2010Journal of clinical pharmacology39 citations
Semantic Scholar
Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
T. Vollmer, A. Blight, H. Henney
2009Clinical Therapeutics38 citations
Semantic Scholar
Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
H. Henney, M. Sperling, A. Rabinowicz, Gary Bream +1 more
2014Epilepsy Research35 citations
Semantic Scholar
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
J. Shah, K. Wesnes, R. Kovelesky, H. Henney
2006Clinical Therapeutics23 citations
Semantic Scholar
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease.
B. Safirstein, A. Ellenbogen, Ping Zhao, H. Henney +2 more
2020Clinical Therapeutics22 citations Open access
Semantic Scholar
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
R. Yapundich, A. Applebee, F. Bethoux, M. Goldman +7 more
2015International Journal of MS Care14 citations Open access
Semantic Scholar
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
Michele Jara, G. Barker, H. Henney
2013Neuropsychiatric Disease and Treatment14 citations Open access
Semantic Scholar
Effect of food on the single-dose pharmacokinetics and tolerability of dalfampridine extended-release tablets in healthy volunteers.
H. Henney, Bonnie Faust, A. Blight
2011American Journal of Health-System Pharmacy13 citations
Semantic Scholar
Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
H. Henney, A. Fitzpatrick, J. Stewart, J. D. Runyan
2008Clinical Therapeutics13 citations
Semantic Scholar
Dalfampridine in chronic sensorimotor deficits after ischemic stroke: A proof of concept study.
D. Simpson, James N. Goldenberg, S. Kasner, Marshall Nash +7 more
2015Journal of Rehabilitation Medicine12 citations Open access
Semantic Scholar
Pharmacokinetics of Dalfampridine Extended Release 7.5-mg Tablets in Healthy Subjects and Individuals With Mild and Moderate Renal Impairment: An Open-Label Study
E. Samara, P. Winkle, P. Pardo, H. Henney +4 more
2013Journal of clinical pharmacology8 citations Open access
Semantic Scholar
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis
S. Weir, Yu-Ying Gao, H. Henney
2013Current Medical Research and Opinion8 citations
Semantic Scholar
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Cecilie Fjeldstad, G. Suárez, M. Klingler, H. Henney +2 more
2015International Journal of MS Care6 citations Open access
Semantic Scholar
Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
H. Henney, J. Shah
2007Clinical Therapeutics6 citations
Semantic Scholar
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis
Michele Jara, M. Sidovar, H. Henney
2014Therapeutics and Clinical Risk Management5 citations Open access
Semantic Scholar
Abstract 150: Dalfampridine in Patients With Chronic Post-Ischemic Stroke Deficits: Results From a Phase 2 Study
D. Simpson, M. Reding, Marshall Nash, S. Kasner +5 more
2014Stroke2 citations
Semantic Scholar
Dosing Feasibility And Pharmacokinetics By Seizure Type And Status, And Tolerability Of Intranasal Diazepam In Adults With Epilepsy (S31.006)
M. Sperling, Hussam Seif Eddeine, Kevin F. Haas, G. Krauss +5 more
2014Neurology2 citations
Semantic Scholar
Degenerative Neurological and Neuromuscular Disease Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets
H. Henney, A. Blight
20122 citations
Semantic Scholar
Assessment of Pharmacokinetic Linearity and Relative Bioavailability of an Intranasal Diazepam Formulation Compared with Diazepam Rectal Gel in Healthy Adult Subjects (P02.214)
Gary Bream, M. Leibowitz, B. Wargin, K. Abernathy +2 more
2013Neurology1 citations
Semantic Scholar
Effects of 5mg and 10mg Dalfampridine Extended Release Tablets on 6-Minute Walk Distance in People with Multiple Sclerosis: A Subgroup Analysis of a Double-Blind, Placebo-Controlled Trial (S01.007)
A. Applebee, A. Goodman, A. Mayadev, F. Bethoux +5 more
2013Neurology1 citations
Semantic Scholar
Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets.
H. Henney, Andrew R. Blight
2012Degenerative Neurological and Neuromuscular Disease1 citations Open access
Semantic Scholar
Pharmacokinetics of inhaled levodopa (administered with oral carbidopa) and oral carbidopa/levodopa in subjects with Parkinson's disease under fed conditions
B. Safirstein, A. Ellenbogen, Ping Zhao, H. Henney +2 more
20200 citations
Semantic Scholar
Original article Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis
S. Weir, Yu-Ying Gao, H. Henney
20130 citations
Semantic Scholar
Volunteers and Adults With Renal Impairment Single-Dose Pharmacokinetics of Sustained-Release Fampridine ( Fampridine-SR ) in Healthy
William B. Smith, S. Swan, T. Marbury, H. Henney
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Blight×8
Invite
A. Blight — researcher profile on SciRah
A. Rabinowicz×5
Invite
A. Rabinowicz — researcher profile on SciRah
Ping Zhao×4
Invite
Ping Zhao — researcher profile on SciRah
Enrique J. Carrazana×4
Invite
Enrique J. Carrazana — researcher profile on SciRah

×3

Invite

F. Bethoux — researcher profile on SciRah

J. D. Runyan×3

Invite

J. D. Runyan — researcher profile on SciRah

Invite

Gary Bream — researcher profile on SciRah

Invite

M. Klingler — researcher profile on SciRah

Invite

G. Suárez — researcher profile on SciRah

Invite

A. Goodman — researcher profile on SciRah

Invite

L. Kamen — researcher profile on SciRah

Invite

T. Vollmer — researcher profile on SciRah